Imaging helps predict head and neck cancer survival

04/4/2013 | AuntMinnie.com (free registration)

A study published in the Journal of Nuclear Medicine found that in patients with head and neck cancer undergoing initial radiotherapy or chemoradiotherapy, a drop of at least 45% in the maximum standardized uptake value on FLT-PET/CT scans and a decrease of at least 31% in gross tumor volume measured using visual delineation were linked with a three-year disease-free survival rate of 88%. Three-year disease-free survival was 63% for other patients. Scans undertaken in the second week of therapy were the most useful in customizing treatment, researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC